Works matching IS 17539447 AND DT 2016 AND VI 10 AND IP 3

Results: 7

Renin–angiotensin system inhibitors in patients with coronary artery disease who have undergone percutaneous coronary intervention.

Published in:

Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 3, p. 172, doi. 10.1177/1753944716648851

By:

Xiao-Dong, Zhuang;
Fei-Fei, Li;
Zhan-Peng, Wen;
Xin-Xue, Liao;
Zhi-Min, Du

Publication type:

Article

Preface.

Published in:

Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 3, p. 116, doi. 10.1177/1753944716645029

By:

Ferrario, Carlos M.;
Wang, Ji-Guang

Publication type:

Article

Mega clinical trials which have shaped the RAS intervention clinical practice.

Published in:

Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 3, p. 133, doi. 10.1177/1753944716644131

By:

Düsing, Rainer

Publication type:

Article

Pharmacological interventions into the renin–angiotensin system with ACE inhibitors and angiotensin II receptor antagonists: effects beyond blood pressure lowering.

Published in:

Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 3, p. 151, doi. 10.1177/1753944716644130

By:

Düsing, Rainer

Publication type:

Article

Vascular ageing and interventions: lessons and learnings.

Published in:

Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 3, p. 126, doi. 10.1177/1753944716642681

By:

Williams, Bryan

Publication type:

Article

Drug discovery in renin–angiotensin system intervention: past and future.

Published in:

Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 3, p. 118, doi. 10.1177/1753944716642680

By:

Williams, Bryan

Publication type:

Article

Cardiac remodelling and RAS inhibition.

Published in:

Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 3, p. 162, doi. 10.1177/1753944716642677

By:

Ferrario, Carlos M.

Publication type:

Article